General Information
As of February 8, 2024
r/survodutide
Survodutide
en
Follow Boehringer Ingelheim's Survodutide, a glucagon/GLP-1 receptor dual agonist medication that is in a clinical trial phase.
N/A
4
December 13, 2023
public
N/A
Restricted Submissions
Total Submissions
1
Total Comments
1
Earliest Submission
December 14, 2023
Earliest Comment
February 2, 2024
Metrics
Activity Over Time
totalSubmissions
totalComments
Submission Flags
score hidden
text submission
stickied
gilded
over 18
saved
locked
collapsed
quarantine
distinguished user
Comment Flags
collapsed
gilded
locked
score hidden
distinguished user
Submission Score Distribution
< 0
0
1-10
11-50
51-100
> 100
Comment Score Distribution
< 0
0
1-10
11-50
51-100
> 100
Title Length
0
1-100
101-500
501-1000
>1000
Submission Text Length
0
1-100
101-500
501-1000
>1000
Comments per Submission
< 0
0
1-10
11-50
51-100
> 100
Most Distinctive Words
2024
Year
2024
Total Words in Subreddit
65,053
Total Words in Reddit
119,924,722,855
Rank↕ | Word↕ | Occurrences in Subreddit | Total Occurrences | Rate in Subreddit (per 1M words) | Rate in Reddit (per 1M words) | Ratio (Sub Rate / Reddit Rate) |
|---|---|---|---|---|---|---|
| #1 | 131 | 291,304 | 2013.7 | 2.4 | 829.02 | |
| #2 | 46 | 111,429 | 707.1 | 0.9 | 761.03 | |
| #3 | 30 | 88,943 | 461.2 | 0.7 | 621.80 | |
| #4 | 35 | 162,120 | 538.0 | 1.4 | 397.99 | |
| #5 | 128 | 649,925 | 1967.6 | 5.4 | 363.07 | |
| #6 | 97 | 812,669 | 1491.1 | 6.8 | 220.04 | |
| #7 | 31 | 289,995 | 476.5 | 2.4 | 197.07 | |
| #8 | 53 | 713,821 | 814.7 | 6.0 | 136.88 | |
| #9 | 248 | 3,376,764 | 3812.3 | 28.2 | 135.39 | |
| #10 | 41 | 743,104 | 630.3 | 6.2 | 101.71 | |
| #11 | 40 | 838,250 | 614.9 | 7.0 | 87.97 | |
| #12 | 104 | 2,790,710 | 1598.7 | 23.3 | 68.70 | |
| #13 | 53 | 1,582,471 | 814.7 | 13.2 | 61.74 | |
| #14 | 68 | 2,242,752 | 1045.3 | 18.7 | 55.89 | |
| #15 | 58 | 1,955,229 | 891.6 | 16.3 | 54.69 | |
| #16 | 83 | 2,992,480 | 1275.9 | 25.0 | 51.13 | |
| #17 | 65 | 2,520,825 | 999.2 | 21.0 | 47.53 | |
| #18 | 204 | 8,074,571 | 3135.9 | 67.3 | 46.57 | |
| #19 | 140 | 6,415,519 | 2152.1 | 53.5 | 40.23 | |
| #20 | 41 | 1,915,402 | 630.3 | 16.0 | 39.46 | |
| #21 | 49 | 2,773,112 | 753.2 | 23.1 | 32.57 | |
| #22 | 50 | 3,541,744 | 768.6 | 29.5 | 26.03 | |
| #23 | 93 | 6,965,341 | 1429.6 | 58.1 | 24.61 | |
| #24 | 181 | 14,481,083 | 2782.3 | 120.8 | 23.04 | |
| #25 | 41 | 3,653,415 | 630.3 | 30.5 | 20.69 | |
| #26 | 46 | 4,104,837 | 707.1 | 34.2 | 20.66 | |
| #27 | 51 | 4,692,116 | 784.0 | 39.1 | 20.04 | |
| #28 | 32 | 3,069,382 | 491.9 | 25.6 | 19.22 | |
| #29 | 106 | 10,488,310 | 1629.4 | 87.5 | 18.63 | |
| #30 | 37 | 3,691,798 | 568.8 | 30.8 | 18.48 | |
| #31 | 123 | 13,307,805 | 1890.8 | 111.0 | 17.04 | |
| #32 | 185 | 21,355,202 | 2843.8 | 178.1 | 15.97 | |
| #33 | 67 | 9,519,866 | 1029.9 | 79.4 | 12.97 | |
| #34 | 30 | 4,885,716 | 461.2 | 40.7 | 11.32 | |
| #35 | 245 | 40,216,177 | 3766.2 | 335.3 | 11.23 | |
| #36 | 39 | 6,600,084 | 599.5 | 55.0 | 10.89 | |
| #37 | 55 | 9,343,736 | 845.5 | 77.9 | 10.85 | |
| #38 | 46 | 9,569,007 | 707.1 | 79.8 | 8.86 | |
| #39 | 119 | 24,754,997 | 1829.3 | 206.4 | 8.86 | |
| #40 | 106 | 22,233,680 | 1629.4 | 185.4 | 8.79 | |
| #41 | 52 | 11,286,361 | 799.3 | 94.1 | 8.49 | |
| #42 | 34 | 7,440,620 | 522.7 | 62.0 | 8.42 | |
| #43 | 154 | 33,802,731 | 2367.3 | 281.9 | 8.40 | |
| #44 | 98 | 21,831,638 | 1506.5 | 182.0 | 8.28 | |
| #45 | 86 | 21,246,630 | 1322.0 | 177.2 | 7.46 | |
| #46 | 82 | 21,508,235 | 1260.5 | 179.3 | 7.03 | |
| #47 | 55 | 14,924,519 | 845.5 | 124.4 | 6.79 | |
| #48 | 42 | 11,409,532 | 645.6 | 95.1 | 6.79 | |
| #49 | 34 | 9,713,707 | 522.7 | 81.0 | 6.45 | |
| #50 | 41 | 12,322,231 | 630.3 | 102.7 | 6.13 |
Showing 50 of 50 words